Strawberries vs. Bananas: Which Fruit Is Better for Blood Sugar? Registered Dietitians Explain

From parade.com

By Beth Ann Mayer

Read this before you blend up your next smoothie 

Between the interest in GLP-1s and desire to ward off the dreaded 3 p.m. slump, blood sugar control has become a buzzy word on social media. Keeping blood sugar in check can indeed protect you against type 2 diabetes (or help you manage it if you have it) and keep you from becoming “hangry” and exhausted in the afternoon. However, registered dietitians like Amanda Sauceda, MS, RD, are noticing a rumour: fruits like bananas and strawberries are “bad” for blood sugar. Is that true? Not quite.

“While fruit is a source of natural sugar, like fructose, it won’t have the same effect on your body when compared to eating candy or refined carbohydrates,” Sauceda tells Parade. “Fruit is a mix of natural sugar along with a variety of vitamins and minerals, as well as fibre, which makes it better for your blood sugar.”

But which one is better for blood sugar: strawberries or bananas? After all, different fruits have distinct nutrient profiles, offering benefits to everything from your immune system to your brain health. When it comes to blood sugar, you can start by looking at the glycaemic index (GI).

“The glycaemic index (GI) is a scale that measures how quickly carbohydrate-containing foods raise blood sugar levels compared to glucose, a form of sugar,” says Kara Dawson, RD, the clinical nutrition manager at HonorHealth Four Peaks Medical Center.

Dawson says the scale ranges from 0 to 100, and high-GI foods (70 or above) cause rapid spikes in blood sugar. Low-GI items are digested slowly (55 and below), so blood sugar rises and falls more gradually. Below, registered dietitians will explain whether strawberries or bananas have a lower GI.

However, that’s not all to keep in mind when evaluating a food’s effect on blood sugar. Registered dietitians present their case for the great food fight—strawberries vs. bananas: Which fruit is better for blood sugar?

XOLODAN/Getty Images

Bananas vs. Strawberries for Blood Sugar

If managing blood sugar is a concern when you eat, strawberries may support you better than bananas. Here’s why:

• Strawberries are a lower-GI food than bananas. Dawson points out that strawberries have a GI of about 40, which classifies them as a low-glycaemic food. A banana’s GI depends on ripeness, with a medium one coming in at about 42-51. But riper bananas can have a GI of 56-85. “Bananas can cause a slightly quicker rise in blood sugar level, even if you eat the same number of calories of strawberries and bananas,” she says.
• Strawberries have a better fibre-to-total-carb ratio than bananas. Technically, bananas have a little more fibre by weight (about 2.6 grams per 100 grams, compared with about 2 grams per 100 grams in strawberries, reports Dr. Chris Mohr, Ph.D., RD, a fitness and nutrition advisor for Garage Gym Reviews). Fibre slows digestion, helping keep blood sugar from rising too quickly after eating. Yet, the fibre edge somehow goes to strawberries. Here’s why: “Strawberries have much fewer carbs overall, so they give you a good amount of fibre for a lower sugar load,” he adds.
• Strawberries are packed with antioxidants to support blood sugar. Dr. Mohr says that strawberries contain anti-inflammatory properties, including vitamin C and anthocyanins (a plant-based compound). Some research suggests that eating strawberries may reduce blood sugar and insulin response when eaten with a higher-carb meal, but this can vary by person.

Quick note: While strawberries edge out bananas for blood sugar, Dr. Mohr notes that it matters how you consume the strawberries. “The main thing to watch is the form, since jams, syrups, sweetened dried strawberries and desserts with strawberries can have a lot of added sugar,” he says.

Bananas vs. Strawberries for Energy

Bananas have components that make them better than strawberries for a sustainable energy boost. Here are RDs’ reasons:

• A medium banana has double the calories as a cup of strawberries. Despite what diet culture would have us believe, calories are not the enemy. Calories simply measure energy—energy that helps us breathe, think, digest food, tissue repair and so many other vital functions,” says Sharniquia White, MS, a culinary dietitian and the founder of YouNiqly Nourishing LLC. “This could make [bananas] better suited for long day snacks or pre-/post-workout, since they provide more energy.”
• A medium banana boasts more than twice the carbs as one cup of strawberries. Carbs aren’t evil, either. “Carbohydrates are the body’s preferred energy source,” White says. “Carbohydrates get broken down into glucose, which then enters the bloodstream and becomes available for cells to produce energy. The brain, muscles and nervous system all heavily rely on carbohydrates for sustained energy.”
• Bananas are a great source of vitamin B6. Sauceda says vitamin B6 helps “unlock the energy from your food.” “After you eat, your body will break down your food, then start to absorb those nutrients,” she explains. “From there, the body uses vitamins, like B6, to convert the food you eat into a fuel source for your cells.”
• Bananas will net you powerful potassium. Potassium is a vital nutrient for your overall health–energy levels included. “Potassium…helps with processes needed for nerve communication, muscle contractions and each cell’s metabolic processes,” Dawson says.

Bananas vs. Strawberries: Nutrients and Other Health Benefits

What does the actual nutrition breakdown for each fruit look like, anyway? Here’s a glance:

	Strawberries	Bananas
Serving size	1 cup, whole	1 medium
Calories	46 calories	105 calories
Total carbohydrates	11 grams	27 grams
Fibre	2.9 grams	3.1 grams
Vitamin C	84.7 mg	10.3 mg
Magnesium	18.7 mg	31.9 mg
Manganese	0.6 mg	0.3 mg
Potassium	220 mg	422 mg
Vitamin B6	0.1 mg	0.4 mg
Folate	34.6 mcg	23.6 mcg

It’s worth noting that strawberries and bananas are both so nutrient-dense that they offer benefits beyond blood sugar and energy. “Because strawberries are packed with vitamin C, they can support iron absorption.” White states. “They are super supportive of hydration, due to their high water content.”

Sauceda says bananas are also a win for gut health. “The resistant starch in green bananas can also act as a prebiotic, which means it can benefit your gut. Prebiotics help to feed your good gut bacteria, which encourages a healthy microbiome.”

https://parade.com/health/strawberries-vs-bananas-for-blood-sugar

How often should people with type 2 diabetes see their GP?

From diabetes.co.uk/news

• A data-driven model suggested people at higher risk may benefit from shorter follow-up intervals when HbA1c rises, while stable lower-risk patients could safely have longer gaps.
• A separate study found the first appointments following a diabetes-range HbA1c were particularly important opportunities to document a diagnosis.
• Both studies used US healthcare data and neither proves that algorithm-based scheduling would improve NHS outcomes.

Seeing a GP more frequently is not automatically better for everyone with type 2 diabetes, according to research investigating how primary-care appointments could be scheduled according to individual risk.

Two studies from researchers at the University of Massachusetts Amherst examined different parts of the type 2 diabetes pathway: how frequently people already diagnosed with diabetes should be reviewed, and how quickly an abnormal HbA1c result leads to a documented diagnosis.

The findings suggest that the organisation of primary care may matter alongside individual patient characteristics.

But they do not support simply replacing existing appointment schedules with an algorithm.

Should higher-risk patients be seen more frequently?

The first study used electronic health records from 10 primary-care practices to develop a mathematical model for choosing follow-up intervals.

Rather than automatically reviewing everyone after one, three or six months, the model adjusted the recommended interval according to the person’s current health and diabetes trajectory.

People in the higher-risk group tended to be older and have more existing conditions such as chronic kidney disease and cardiovascular disease.

When HbA1c increased, the model favoured more frequent follow-up in these patients.

For lower-risk people whose glucose remained stable, it allowed longer intervals between appointments.

The model performed better on its mathematical optimisation measure than fixed appointment schedules, including a benchmark based on American Diabetes Association recommendations.

The basic idea is straightforward.

Seeing someone again too soon may provide little new information because HbA1c reflects blood glucose over approximately the previous two to three months.

Waiting too long, however, could allow worsening glucose control to go undetected.

A personalised schedule tries to find the point between those two extremes.

This was a modelling study – not a trial of patient outcomes

That distinction is important.

Researchers did not randomly assign thousands of people to algorithm-selected appointment intervals and then show fewer diabetes complications.

Instead, they used existing electronic health records to build and evaluate a Markov decision model.

Its better performance refers to the model’s predefined optimisation criteria.

It does not yet prove that the approach reduces hospital admissions, kidney disease, cardiovascular complications or mortality in real clinical practice.

A prospective trial would be needed before drawing those conclusions.

A second study examined delays in diagnosis

A separate study investigated 594 adults attending two US primary-care clinics between 2017 and 2023.

All had recorded an HbA1c in the diabetes range – at least 6.5%, equivalent to 48 mmol/mol – before receiving a documented diagnosis of type 2 diabetes.

The median time from the first diabetes-range HbA1c to diagnosis differed between the two clinics, at approximately 1.6 months and two months.

The investigators found that the first few appointments following the abnormal HbA1c appeared to be particularly important opportunities for diagnosis.

However, this finding needs nuance.

After adjustment for other factors, the study did not find statistically significant associations between primary-care location, continuity of care or visit regularity and time to diagnosis.

It would therefore be too strong to conclude that staffing levels or the clinic someone attends have been proven to cause diagnostic delays.

The study was exploratory and involved only two practices.

The researchers argue that differences in staffing, appointment availability and local practice processes deserve further investigation.

Why might diagnosis be delayed?

An HbA1c result does not operate in isolation.

Clinicians may need to repeat tests, review symptoms, rule out factors that can distort HbA1c and consider whether another form of diabetes is possible.

Diabetes.co.uk has guides explaining how diabetes is diagnosed and how the HbA1c test is used in type 2 diabetes.

The healthcare system also has practical constraints.

Appointments may be missed or delayed, laboratory results need reviewing and primary-care teams differ in workload and staffing.

That makes the period immediately following an abnormal result an obvious place to examine whether patients are being lost between testing and treatment.

What could this mean for the NHS?

The studies were conducted using US healthcare data, so the results cannot simply be transferred to NHS general practice.

The UK has different diagnostic pathways, staffing structures, diabetes reviews and commissioning arrangements.

But the underlying question is relevant.

People with type 2 diabetes are highly heterogeneous.

Someone with stable glucose, few complications and a consistent treatment regimen may not need exactly the same follow-up frequency as someone whose HbA1c is rising rapidly alongside kidney or cardiovascular disease.

More appointments are not automatically better if they add workload without changing care.

Equally, leaving a higher-risk person too long between reviews may delay medication changes or recognition of complications.

The potential value of the research is therefore risk-based follow-up, rather than simply increasing or reducing appointment numbers for everyone.

Before an algorithm like this could be used in the NHS, it would need prospective UK validation and evidence that it improves clinically meaningful outcomes without widening inequalities or making access harder for people who need support.

The studies make a sensible case for personalising follow-up.

They do not yet prove the best schedule for doing it.

https://www.diabetes.co.uk/news/2026/oct/how-often-should-people-with-type-2-diabetes-see-their-gp.html 

One Blood Type Seems to Carry a Higher Risk of Type 2 Diabetes

From health.yahoo.com

By Michelle Starr

Depending on your blood type, it's possible you could carry a higher diabetes risk, research suggests.

According to a 2024 review, people with blood type B – either positive or negative – face a slightly higher risk of developing type 2 diabetes than people with non-B blood types.

How much higher? 

About 28 percent, on average. That might not seem huge, but it may be significant enough to tip the scales if other risk factors are involved.

"Numerous systematic reviews with meta-analyses have been published, which explored correlations between ABO and Rhesus blood groups with various health outcomes," wrote a team led by epidemiologist Fang-Hua Liu of Shengjing Hospital of China Medical University.

"However, to date, the association between these blood groups and human health outcomes remains controversial. The current umbrella review included 51 systematic reviews with meta-analysis articles with 270 associations.

"We recalculated each association and found only one [instance of] convincing evidence for an association between blood group B and type 2 diabetes mellitus risk compared with the non-B blood group."

(Douglas Sacha/Moment/Getty Images)

Human blood is categorized into eight main groups based on the sugars and proteins, or lack thereof, present on the surface of your red blood cells.

A, B, and AB types are based on the presence of antigens – sugar molecules that can trigger an immune response. O-type blood has no A or B antigens. Meanwhile, Rhesus (Rh) factors are proteins that determine blood compatibility and give your blood its positive or negative designation.

Previous studies have suggested that these subtle differences in our blood cells may be linked to increased vulnerability to certain diseases.

Liu and colleagues embarked on their study to systematically evaluate links between blood type and disease across a catalogue of around 270 different health outcomes.

A systematic review is a study that reviews published papers on a given topic and analyses their results collectively. An umbrella review compiles systematic reviews – a sort of giant synthesis that provides a wider overview.

Think of individual studies as trees; a systematic review is like standing outside a copse, while an umbrella review is like flying a drone over a whole forest of copses.

Blood type (or blood group) is partly determined by the ABO blood group antigens present on red blood cells. 

Antibodies in our blood plasma detect when a foreign antigen marker is present.  (InvictaHOG/Wikimedia Commons/public) domain)

"We systematically searched PubMed, Web of Science, Embase, Scopus, Cochrane Library, and several regional databases on the date from inception until Feb 16, 2024, to identify systematic reviews with meta-analyses of observational studies evaluating associations between ABO as well as Rh blood groups and diverse health outcomes," the researchers explained.

To sort through the 270 reported links between blood group and disease, the researchers put each one through a series of statistical stress tests designed to weed out weak or unreliable findings.

They examined the strength of the evidence, whether results were consistent across different studies, and whether the datasets were large enough to be trustworthy.

They also checked for signs of bias, such as small studies exaggerating effects or an unusually high number of positive results.

Crucially, they asked whether each association would likely hold up if tested again in future research. Most of the associations didn't pass these checks.

In the end, just one link, between blood type B and type 2 diabetes, met the highest standard of evidence.

That suggests that the link is real, albeit relatively small: just 28 percent higher than the current baseline. That's much smaller than the risk associated with diet, weight, or lifestyle.

Just 50 grams of processed meat a day, for example, increases the risk of type 2 diabetes by 37 percent. A sedentary lifestyle can increase the risk by 112 percent. And being overweight is one of the strongest risk factors known.

The researchers also didn't examine what might drive this increased risk. A 2025 study suggests that the gut microbiome may be involved; however, further investigation is needed.

The results do suggest that there's a real, tangible association between blood type and type 2 diabetes – one that people can factor into how they think about their own risk.

Still, your blood type alone won't make or break your diabetes risk. Diet, activity levels, and weight matter far more – this is just one more piece of a puzzle scientists are still putting together.

The research was published in BMC Medicine.

https://health.yahoo.com/conditions/endocrine/diabetes/articles/one-blood-type-seems-carry-200000511.html